Taro pharmaceutical industries ltd (TARO)
Income statement / TTM
Mar'12Mar'11
Sales, net

0

0

Cost of sales

0

0

Gross profit

0

0

Operating expenses:
Research and development

0

0

Selling, marketing, general and administrative

0

0

Settlements and loss contingencies

0

-

Total operating expenses

0

0

Operating income

0

0

Financial expenses (income), net

0

0

Other gain, net

0

0

Income before income taxes

0

0

Tax expense

0

0

Income from continuing operations

0

0

Net loss from discontinued operations attributable to Taro

0

0

Net income

0

0

Net (loss) income attributable to non-controlling interest

0

0

Net income attributable to Taro

0

0

Net income from continuing operations attributable to Taro

0

0

Net loss from discontinued operations attributable to Taro

0

0

Net income attributable to Taro

0

0

Basic

1.06

0.58

Diluted

1.06

0.58

Basic

0.00

0.00

Diluted

0.00

0.00

Net income per ordinary share attributable to Taro:
Basic

1.06

0.58

Diluted

1.06

0.58

Weighted-average number of ordinary shares used to compute net income per share:
Basic

44,476,000

44,285,000

Diluted

44,589,000

44,447,000